Phase 2 Trial of R/R Diffuse Large B-cell Lymphoma Treatment Is Now Enrolling Patients
News
ProNAi Therapeutics, Inc, a clinical stage oncology company that develops therapeutic drugs based on its proprietary DNA interference (DNAi) technology platform, is currently enrolling patients in Wolverine, a clinical trial ... Read more